BCWM
RPRX icon

Bartlett & Co Wealth Management’s Royalty Pharma RPRX Stock Holding History

Bartlett & Co Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168 Hold
3
– – ﹤0.01% 1286
2026
Q1 		$151 Buy
+3
New +$131 ﹤0.01% 1227
2024
Q2 		– Sell
-95
Closed -$2.88K – 1167
2024
Q1 		$2.88K Buy
+95
New +$2.8K ﹤0.01% 1013

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bartlett & Co Wealth Management's RPRX Position: Q2 2026 in Review

Bartlett & Co Wealth Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 3 shares worth $168. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Bartlett & Co Wealth Management first reported a position in RPRX in Q1 2024 and has held it in 3 quarters since. The position peaked at $2.88K in Q1 2024. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Bartlett & Co Wealth Management held 3 shares of Royalty Pharma worth $168 as of Q2 2026.
  • Bartlett & Co Wealth Management left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1286 holding.
  • Bartlett & Co Wealth Management first reported a position in Royalty Pharma in Q1 2024 and has held it in 3 quarters since.
  • Bartlett & Co Wealth Management's Royalty Pharma position peaked at $2.88K in Q1 2024.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.